NasdaqCM - BOATS Real Time Price USD
Regencell Bioscience Holdings Limited (RGC)
8.56 -2.52 (-22.74%)
At close: June 24 at 4:00:01 PM EDT
8.81 +0.25 (+2.92%)
Overnight: 11:26:01 PM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trade RGC on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for RGC
Chart does not reflect overnight price.
- Previous Close
11.08 - Open
10.63 - Bid 7.64 x 200
- Ask 11.14 x 200
- Day's Range
8.55 - 11.00 - 52 Week Range
8.55 - 69.00 - Volume
468,670 - Avg. Volume
147,343 - Market Cap (intraday)
4.233B - Beta (5Y Monthly) 1.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date (est.) Jun 15, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RGC
59.24%
S&P 500 (^GSPC)
7.49%
1-Year Return
RGC
62.70%
S&P 500 (^GSPC)
20.78%
3-Year Return
RGC
1,284.17%
S&P 500 (^GSPC)
69.22%
5-Year Return
RGC
2,610.67%
S&P 500 (^GSPC)
72.47%
Statistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
5.40B
Enterprise Value
5.39B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.43k
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-84.97%
Return on Equity (ttm)
-177.66%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-7.05M
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
2.36M
Total Debt/Equity (mrq)
31.68%
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
8.56
-22.74%
Mkt Cap 4.233B
Industry Drug Manufacturers—Specialty & Generic
4.9900
-0.80%
Mkt Cap 625.996M
Industry Drug Manufacturers—Specialty & Generic
2.5400
+2.42%
Mkt Cap 11.324M
Industry Drug Manufacturers—Specialty & Generic
32.70
-0.79%
Mkt Cap 7.569B
Industry Drug Manufacturers—Specialty & Generic
34.22
+3.04%
Mkt Cap 39.847B
Industry Drug Manufacturers—Specialty & Generic
4.5900
-0.43%
Mkt Cap 554.556M
Industry Drug Manufacturers—Specialty & Generic
0.9217
-2.59%
Mkt Cap 413.305M
Industry Drug Manufacturers—Specialty & Generic
3.2500
-1.81%
Mkt Cap 38.885M
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.